Your Health and Fitness Partner: Androxal & FitHub

We are also excited to expand our scope by including valuable information on Androxal, a potent medication beneficial in various medical conditions. This remarkable drug, derived from the testosterone molecule, has made its mark significantly in the field of endocrinology. Patients and medical professionals can rely on our comprehensive, unbiased, and scientifically grounded content on Androxal for gaining a robust understanding of its uses, side effects, and the latest studies related to it. We understand the necessity of accurate information when it comes to medication. Our newly launched section dedicated to Androxal aims at not only educating the readers about its nuances but also at contributing beneficially to their wellbeing. Stay tuned for insightful articles unraveling the potential of Androxal in medical science.

Sitemap | Policies | Feedback    
 About the Journal
Editorial Board
Journal Subscription
Instructions for Authors
E-mail Alerts
Forthcoming Events
Advertise with Us
Contact Us
 
Article Options
FULL TEXT
ABSTRACT
PDF
Printer Friendly Version
Search Pubmed for
Search Google Scholar for
Article Statistics
Bookmark and Share
 
Body composition in Indian patients with Crohn’s disease during active and remission phase
 
Jaya Benjamin, Govind Makharia, Vineet Ahuja, Yogendra Kumar Joshi
Department of Gastroenterology
and Human Nutrition,
All India Institute of Medical Sciences,
New Delhi – 110029, India


Corresponding Author
: Dr. YK Joshi
Email: ykj2511@usa.net


Abstract

Background: The alterations in the body composition (BC) in both the active and remission phase of Crohn’s disease (CD) are poorly characterized.

Objective: To assess the BC of the patients with CD in active and remission phase, and compare with healthy controls (HC).

Methods: BC was assessed by bioelectrical impedance analysis using Tanita TBF-215 leg to leg portable impedance analyzer in 123 patients with CD and 100 matched HC. Diet intake was assessed by 24 hours diet recall method.

Results: The mean age of patients was 36.4+12.6 years and 56% were males. Patients in active phase as well as in remission phase had a lower BMI than HC (18.8+3.6 vs. 23.9+4.0; p=0.001 and 18.8+3.6 vs. 21.6+5.0; p=0.002). The fat mass (FM) in active phase was significantly lower than that in remission phase (8.2+5.9 vs. 13.4+10.6 kg; p=0.005) and HC (8.2+5.9 kg vs. 14.1+7.5 kg; p=0.001). FM did not differ between remission phase and HC. The fat free mass (FFM) of HC was significantly higher than that of both remission phase (48.9+7.4 kg vs. 43.3+10.4 kg; p=0.001) and active phase (48.9+7.4 kg vs. 40.7+8.5 kg; p=0.001). There was no difference in the FFM of patients in both phases; p=0.356. The intake of macronutrients was comparable between the two phases; however lower than that of HC.

Conclusion: Both FM and FFM were depleted in the active phase, while only FFM was deficient in the remission phase of CD, indicating a poor recovery of lean mass in remission.